|
Sources:The
rhizoma of Atractylodes macrocephala Koidz. Farmily
Compositae.
Constituents:
Containing atractylol, atractylon, atractylenolide, volatile
oil, etc.
Actions:In vivo
test showed that the volatile oil has inhibitory action against
S180 and EAC murine tumors, the inhibitory rates were 31%~49%
for S180.The volatile oil has cytocidal effect against EAC
cells in vitro. Atractylenolide B also has inhibiting tumor
effect for S180 in vivo and for human esophageal
cancer cells in vitro, the inhibitory rate was more than 30%.
Indications:It
was used for treatment of gastric, esophageal, liver and lung
cancer, etc.
(1) Distilled liquid of the herb used to treat 17 cases of
advanced esophageal cancer with iv. administration. The clinical
result showed that remarkable effect was in 2 cases and effecticeness
was in 8 cases.
(2) Formula for hepatocarcinoma:
Rhizoma Atractylodis 12g
Macrocephalae Preparata
Radix Pseudostellariae 12g
Poria 30g
Cortex Moutan 12g
Flos Lonicerae 30g
Herba Selaginellae Moellendorfii 30g
Radix Kalimeridis Indicae 30g
Concha Ostreae 30g
Spica Prunellae 12g
Squama Manitis Preparata 12g
Carapax Trionycis Preparata 12g
Fols Rosae Rugosea 9g
Fructus Mume 9g
Scolopendra 3 pieces
Lumbricus 12g
Fructus ARebiae 15g
Rhizoma Arisaematis 15g
Decoction of the herbs was taken to treat
123 cases of primary or secondary hepatocarcinoma. The clinical
result showed that more than 1 year of survival time was in
40 cases and survival rate of one year was 32.5%.
|
